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Abstract  
BACKGROUND: Routine iron and folic acid supplementation in pregnancy have been proved to be effective in 
reducing the prevalence and morbidities of anaemia. However, there is limited data regarding the prescription 
habits of physician obstetric care givers.
 
AIM: This study set to investigate the attitudes and factors which influence the practice among physicians in 
University of Calabar Teaching Hospital (UCTH). 
MATERIAL AND METHODS: A questionnaire based cross-sectional survey was conducted among randomly 
recruited physician offering antenatal services between August and September 2015. Systemic sampling was 
used to select 70 doctors in the departmental duty roster. Data were presented in percentages and proportion. 
Chi-square test was used to test the association between variables. Statistical significance was set at p < 0.05. 
RESULTS: The response rate was 100%. The mean age of the respondents was 30.26 ± 6.67 years. All the 
respondents routinely prescribed haematinics to pregnant women but 34.3% of them did not prescribe to 
apparently healthy clients in their first trimester. Only 30% and 11.4% of them prescribed it in the postnatal and 
preconception periods respectively. Brands that contained iron, folate and vitamins as a single capsule were 
mostly favoured, and information about brands of drugs was mostly provided by the pharmaceutical sales 
representatives. Younger doctors were more likely to offer haematinics with nutritional counselling compared to 
older respondents. However, there was no significant relationship between haematinics prescription and sex (p = 
0.3560), Age (p = 0.839), current professional status (p = 0.783), and client complaint of side effect of medication 
(p = 0.23). Oral medication was mostly utilised.
 
CONCLUSION: Effort to effectively control anaemia in pregnancy should involve re-orientation of physician 
obstetric care providers especially about prenatal and postnatal medication and counselling. 
 
 
 
 
 
 
Introduction 
 
Routine administration of haematinics is 
encouraged in pregnancy in the background of the 
high prevalence of anaemia in the general population 
[1]. The WHO has recognised the problem of iron 
deficiency anaemia in the general population as the 
most common debilitating nutritional deficiency 
worldwide in the twenty-first century [2]. It is estimated 
that anaemia may complicate up to 57% of 
pregnancies in Sub-Saharan Africa [2]. 
 
It has also been reported that anaemia may 
be responsible for as much as 20% of all maternal 
deaths in Sub-Sahara Africa through various 
mechanism [3]. Anaemia makes women more 
susceptible to deaths from peripartum haemorrhage 
by lowering their haemoglobin reserves for blood loss; 
severe anaemia may be associated with increased 
susceptibility to infection due to lowered resistance to 
disease and also carries the risk of cardiac and 
respiratory failure during delivery and immediate 
postpartum period. Such problem if ignored and not 
addressed properly, can have a devastating effect on 
the entire population with serious consequences.
 
 The normal daily requirement for a pregnant woman 
is about 20mg of iron [4]. An average diet in most 
communities seldom contains more than 15mg of iron 
a day. And of the total amount of iron in food, only a 
fraction (about 10%) of iron is available for absorption 
[4,5]. The most suitable mass intervention to prevent 
anaemia in pregnancy is the administration of iron 
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with folic acid to pregnant women aimed at increasing 
the haemoglobin concentration so that the level of 
anaemia could be significantly reduced [6-9]. 
 
However, effectiveness and success of such 
antenatal intervention programme depend on several 
factors including not only the attitude and compliance 
of the patients but to some extent the behaviour and 
practice of the obstetric care giver [10].
 
 Most studies on the utilisation and effectiveness of 
antenatal iron and folic therapy/supplementation tend 
to focus on patients factors such as level of 
awareness and adherence to the prescribed 
medication while little is said about the practitioner's 
prescription pattern and attitude. Compliance to 
prescribed medication to a large extent is influenced 
by counselling, doctor's advice, prescription pattern 
and side effect profile which are rarely reported. 
Hence this work seeks to establish the attitude and 
factors which influence the prescription pattern of 
haematinics to pregnant women in the tertiary 
hospital. It is hoped that the findings from this study 
will help to address some anomalies in the 
prescription pattern of these drugs.
 
 
 
Materials and Methods 
 
Study area and study site 
The research was conducted at the University 
of Calabar Teaching Hospital out-patient Antenatal 
Clinic. The hospital is the only public tertiary health 
facility in Calabar Metropolis, the capital of Cross 
River State of Nigeria that cares for pregnant women. 
The antenatal record revealed that between 1200 and 
1700 pregnant women are seen in the clinic per year. 
Except for patients who are insured under National 
Health Insurance Scheme (NHIS), each pregnant 
woman is usually expected to pay a 
booking/registration fee for Antenatal Care (ANC) and 
purchase her medication. In a previous study, the 
prevalence of anaemia among pregnant women in 
Calabar was 59.6% [11]. At the time of the study, 
there were about 60 specialist doctors (consultants, 
senior registrars and registrars) and 45 interns and 
doctors from another department on posting in 
obstetrics.
 
 
Antenatal clinic setting 
The general ANC clinic runs from 08.00 to 
14.00 hours on Mondays, Tuesdays, Thursdays and 
Fridays. The hospital practices routine antenatal 
schedules 4-weekly visit for the 1
st
 28 weeks there 
after two weekly till 36 weeks then weekly till delivery. 
Booking for ANC is done on Wednesdays. For those 
with no problem, prescriptions for Iron and folic acid, 
malaria prophylaxis, Intermittent Preventive Treatment 
with sulfadoxine pyrimethamine (IPT-SP), are 
routinely given.
 
 
Study population 
The study population comprised all cadres of medical 
doctors offering antenatal care in obstetrics and 
gynaecological department of the University of 
Calabar Teaching Hospital. 
 
Study design 
This questionnaire based descriptive cross-
sectional survey. 
 
Sampling and data collection 
The study was conducted among physician 
obstetric care givers in UCTH antenatal clinic from 1
st
 
August to 30
th
 September 2015. Systemic sampling 
was used to recruit participants using the 
departmental nominal roll. The categories of doctors 
included interns, resident doctors and consultants. 
The questionnaires extract information in 
demographic characteristics, routine haematinic 
practices during prenatal, antenatal and postnatal 
periods, reasons for prescription, commonly preferred 
route, choice of medication, sources of information 
about brands of haematinics and factors influencing 
their practices.
 
 
Data management 
Questionnaires were inspected for completion 
and manually sorted and coded. Then data were 
entered into computer software for analysis using 
SPSS version 20. The results were expressed as 
percentages and proportions, means and standard 
deviation were used to summarise variables. To 
compare the differences between means of variables, 
the chi-square test was used and p-value < 0.05 was 
considered statistically significant. 
 
Ethical consideration 
A formal approval was obtained from the 
hospital research ethics community before the 
commencement of the study. Informed consent was 
obtained from every respondent. Data extracted were 
confidentially handled.
 
 
Results  
The response rate was 100%. The mean age 
of the respondents was 30.26 ± 6.67 years. All the 
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physicians sampled have prescribed haematinics to 
pregnant women in the preceding one month. The 
socio-demographic characteristics of respondents are 
presented in Table 1. Oral haematinics were the main 
route of administration. However, 12 (17.1%) of the 
participants have prescribed parenteral iron in the 
preceding six months. Their main indications for the 
parenteral administration were moderate to severe 
anaemia especially close to delivery time, perceived 
poor compliance to oral iron therapy by the clients, 
and as an alternative to blood transfusion especially in 
women who refuse a blood transfusion on religious 
ground. The parenteral iron prescribed included iron 
dextran and sorbitol. No serious side effect or drug 
reaction was reported during their last three months of 
practice.
 
Table 1: Socio-demographic characteristics of study 
participants 
Parameter                                Frequency                   Percentage (%) 
Age group/years 
22-26                                            24                               34.3 
27-31                                            23                               32.9 
32-36                                            13                               18.6 
37-41                                              3                                 4.3 
42-46                                              5                                 7.1 
47-51                                              2                                 2.9 
                                               Mean age ± SD  30.26 ± 6.67 
Sex 
Male                                              38                              54.3 
Female                                          32                              45.7 
Marital status 
Married                                          30                              42.9 
Single                    40                              57.1  
Current professional status  
 House Officer                               34                              48.6 
 Registrar                                       26                              37.1 
 Senior Registrar                              7                              10.0 
 Consultant                                      3                                4.3 
  
 Regarding the brands of haematinics, as shown in 
Fig. 1, a combination drug containing iron, folic acid, 
micronutrients and vitamins as a single capsule or 
tablet were highly favoured by 75.2% of them and 
Ranferron – 12 (marketed by the Ranbansy 
pharmaceutical company), was the most common oral 
preparation in this group and was prescribed in 24.8% 
of the cases. This was followed by fergon and folic 
acid (22.8%). The reason for preferring combination 
drug like Ranferon - 12 was due to single 
capsule/tablet per day dose to enhance compliance. 
However, more than 50% of the respondents did not 
remember the exact amount of elemental iron in the 
drug prescribed. Six (8.6%) of the practitioners 
admitted giving more than one brand at a time 
especially when there was clinical or laboratory 
evidence of anaemia. All the respondents believed 
that oral haematinics are as effective as parenteral 
ones in treating mild to moderate anaemia in 
pregnancy remote from term. 
 
Participants were asked to state the main 
source of information they take into account in their 
choices of medication and the responses were: 
pharmaceutical sales representatives (40%), medical 
libraries and the internet (24.3%), medical textbooks 
(17.1%), publications and journals (14.3%), and 
others such as mass media (4.3%). 
 
Figure 1: Brands of iron supplement prescribed and utilised among 
respondents
 
 
Factors influencing their prescription 
behaviour and their basic criteria for choosing a drug 
include patients' preference, proven clinical efficacy, 
recommended daily dose, the cost of the medication, 
and pharmaceutical delivery mode.  
 Forty (57.1%) of the doctors routinely offer to counsel 
to their clients on nutrition and medication adherence. 
Doctors who were aged 31 years and above, female, 
and higher cadre were less likely to offer nutritional 
counselling to ANC clients, and those whose clients 
did not report the adverse effect of oral medication 
were more likely to prescribe haematinics routinely. 
Table 2 shows the relationship between respondents-
related factors and haematinics prescription. There 
was no significant relationship between haematinics 
prescription and age (p=0.839), sex (p=0.3560) 
marital status (p=0.383), current professional status 
(p=0.783), nutritional counseling (p=0.850) and client 
complaints (p=231).
 
Table 2: Relationship between respondents-related factors and 
haematinics prescription 
                                         Haematinics Prescription 
Variable                        Yes          No           Total            Chi-Square Test       P-value 
                                   N (%)       N (%)        N (%) 
Age group 
22-26                       24 (100.0)   0 (0.0)    24 (100.0)                   2.073           0.839 
27-31                       22  (95.7)    1 (4.3)    23 (100.0) 
32-36                       13 (100.0)   0 (0.0)    13 (100.0) 
37-41                         3 (100.0)   0 (0.0)     3 (100.0) 
42-46                         5 (100.0)   0 (0.0)     5 (100.0) 
47-51                         2 (100.0)   0 (0.0)     2 (100.0) 
Sex 
Male                         37 (97.4)    1 (2.6)    38 (100.0)                   0.854          0.356 
Female                     32 (100.0)   0 (0.0)    32 (100.0) 
Marital status 
Married                     30 (100.0)   0 (0.0)    30 (100.0)                   0.781          0.383 
Single                       39 (97.5)    1 (2.5)     40 (100.0) 
Current professional Status 
House Officer           33 (97.1)     1 (2.9)     34 (100.0)                  1.074          0.783 
Registrar                   26 (100.0)   0 (0.0)     26 (100.0) 
Senior Registrar          7 (100.0)   0 (0.0)       7 (100.0) 
Consultant                  3 (100.0)   0 (0.0)       3 (100.0) 
Gave nutritional counseling? 
Yes                           56 (98.2)    1 (1.8)     57 (100.0)                   0.231         0.631 
No                            13 (100.0)   0 (0.0)    13 (100.0) 
*Believe HMSPDFPC? 
Yes                           52 (98.1)    1 (1.9)     53 (100.0)                   0.325         0.850  
No                            17 (100.0)   0 (0.0)     17 (100.0) 
*Your clients complain of S/Es? 
Yes                          28 (96.6)     1 (2.4)     29 (100.0)                   1.434         0.231 
No                            41 (100.0)   0 (0.0)     41 (100.0) 
HMSPD = Haematinics Makes Significant Positive Difference For Pale Clients; S/Es = 
Side Effects. 
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Fig. 2 shows that the commonest reported 
side effects of oral iron medication were nausea and 
vomiting. 
 
Figure 2: Side effects reported by some respondents 
  
Concerning the timing for commencement of 
haematinics, 51 (72.9%) of them believed that the 
medication should be commenced as early as 
possible and given throughout the period of 
pregnancy while the remaining prefer to give only folic 
acid (without iron) in the first trimester except there is 
clinical or laboratory evidence of anaemia. They 
suggested the risk of iron toxicity as being the reason 
they do not routinely give iron in the first trimester 
even though there was none reported among their 
clients in the preceding three months. Apart from the 
antenatal period, only 20 (40%) of the respondents 
prescribed iron supplement during the postnatal 
period whereas only 13 (18.6%) recommended 
preconception folic acid to their clients in subsequent 
conception in the last six months.
 
 Figure 3 shows the factors that influence or 
inform the prescription of haematinics among doctors 
offering antenatal care (ANC). The most common 
factor was routine practice as departmental/hospital 
policy (32.2%), followed by concern about maternal 
wellbeing (23.1%), then fetal wellbeing (22.4%), and 
other factors as shown. 
 
Figure 3: Factors that influence or inform prescription of 
haematinics among physicians offering ANC in UCTH 
Discussion 
  
This study revealed that the effectiveness of 
iron supplementation in reducing the menace of 
anaemia in pregnancy on the mother and newborn 
child is not only hindered by factors such as supply 
problem and poor adherence by patients to the 
regimens but very importantly, by the attitude of the 
skilled care providers who prescribe or administer the 
medication. The study shows that although all the 
respondents studied had prescribed iron medication to 
pregnant women routinely in the preceding three 
months, but a significant proportion of them did not 
prescribe iron supplementation in pre-conception, first 
trimester and post partum period. Furthermore, many 
of the practitioners especially the older ones did not 
routinely offer counselling on nutrition and drug 
adherence during pregnancy. This is a deviation from 
global recommendation. WHO recommends that all 
pregnant women in countries with high prevalence of 
anaemia should receive daily oral iron and folic acid 
as part of antenatal care to reduce the risk of low birth 
weight and maternal anaemia [12] Iron and folic acid 
supplementation should begin as early as possible. 
The dose of 30-60mg of elemental iron and 400ug of 
folic acid per day as recommended throughout 
pregnancy. As the neural tube closes by day 28 of 
pregnancy, when pregnancy may not have been 
detected, folic acid supplementation should be started 
during the preconception period to prevent neural tube 
defects [12].
 
 The study also reveals that combination brands of 
haematinics (iron, folate, vitamins and other 
micronutrients) were preferred by a significant number 
of the respondents. The commonest brand 
utilised/prescribed here was Ranferron - 12. Others 
include Astyfer, Ferrotone and pregnane. Among the 
reasons given for this were easy dosing-single 
capsule per day instead of multiple tablets, patients' 
compliance and knowledge about the drug facilitated 
by pharmaceutical representatives. This is in line with 
the United Nation recommendation. According to 
United Nations, multiple micronutrient preparations in 
addition to folic acid and iron supplements may be 
formulated to include other vitamin and minerals to 
overcome other possible macronutrient deficiency 
[13]. 
 
Also, WHO [14] recommended that as a 
standard, all pregnant women in areas of high 
prevalence of malnutrition should routinely receive 
haematinics, with appropriate dietary advice to 
prevent anaemia in pregnant women and where the 
prevalence is as high as 40% or more, 
supplementation should continue for three (3) months 
in the postpartum period. This is particularly important 
in areas of low iron reserve in women with high parity 
and short inter-pregnancy intervals.
 
In this study, although offering iron and folic 
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acid to pregnant women was routinely done 
irrespective of maternal haemoglobin status, 
counselling on medication adherence and proper 
nutrition was seldom done especially among the high 
cadre of practitioners. Previous studies have shown 
that educating the pregnant women on health issues 
by doctors is positively associated with increased 
adherence to iron medication [15, 16]. 
 Concerning the factors that influenced the attitudes of 
the physician in prescribing a particular type/brand of 
haematinic, drug cost, patients concern, patients' 
preference and side-effects were factors taken into 
consideration. This finding is in line with those of other 
researchers regarding physician prescribing behaviour 
and attitude [17-19]. Results in Denmark showed that 
drug price was considered an important factor 
influencing physician significantly [17]. Reichert et al. 
showed in their study that physician believed that the 
cost of medicines was an important criterion for drug 
prescription especially when the patient was not 
insured [18].
 
 As the majority of the respondents received 
information about the drug from the pharmaceutical 
representatives more than other sources such as 
textbooks or internets, it is possible that this might 
have influenced the choice of brands of haematinics 
patronised by these practitioners. Most of the time 
marketers, to promote their products, may be bias or 
may even provide some inducement. Other studies 
have shown that publications and pharmaceutical 
sales representations were the most popular sources 
of information about drugs and that these significantly 
influenced the prescribing pattern [18, 19].  
In conclusion, the findings of this research 
revealed that although routine iron and folate 
supplementation was widely practised among the 
obstetric care givers, a significant proportion of them 
do not prescribe them in the 1
st
 trimester, prenatal and 
postnatal period despite the high prevalence of 
anaemia in pregnancy. As iron deficiency anaemia 
remains a public health problem especially among 
pregnant women, its control requires a holistic 
approach and re orientation of physicians involved in 
antenatal care services as this may enhance the 
success of the intended intervention. 
 
 
Acknowledgement 
 
The authors would like to appreciate all the 
doctors in the Department of Obstetrics and 
Gynaecology, University of Calabar Teaching 
Hospital, Calabar including the respondents who took 
part in the survey. We also appreciate research 
assistants who entered the data in computer software 
for analysis.  
References 
1. Strong J. Haematinics deficiencies, In: The Obstetric 
haematology manual (Sue P & Hin B edn). Cambridge University 
Press, 2010; 2: 13-27. 
2. Letssky EA. Erythropoeisis in pregnancy. J of Perinat Med. 
1995; 23:39-45. https://doi.org/10.1515/jpme.1995.23.1-2.39  
3. Buseri FI, Uko EK, Jerimiah ZA, Usanga EA. Prevalence and 
Risk Factors of Anaemia among Pregnant Women in Nigeria. The 
Open Haematology Journal. 2008; 2:14-19. 
https://doi.org/10.2174/1874276900802010014 
 
4. Damen JG, Banwat EB, Egah DZ, Allanana JA. Parasitic 
contamination of vegetables in Jos, Nigeria. Ann Afr Med. 2007; 
6(3): 115-8. https://doi.org/10.4103/1596-3519.55723 
PMid:18240499  
 
5. Galloway R, McGuire J. Determinants of compliance with iron 
supplementation: Supplies, side effects, or psychology. Social 
Science & Medicine. 1994; 39: 381-390. 
https://doi.org/10.1016/0277-9536(94)90135-X 
 
6. Allen LH. Anaemia and iron deficiency, effects on pregnancy 
outcome. Am J Clin Nutr. 2000; 7 (Suppl): 1288s-1294s.  
7. Scholl OT, Johnson WG. Folic acid influence on the outcome of 
pregnancy. Am J Clin Nutr. 2000; 71 (Suppl): 1295s-1303s. 
PMid:10799405  
 
8. Seck BC, Jackson RT. Determinants of compliance with iron 
supplementation among pregnant women in Senegal. Public 
Health Nutrition. 2008; 11(6); 596-625. 
https://doi.org/10.1017/S1368980007000924 PMid:17764606  
 
9. Mithra P, Unnikrishnan, Aganwal D. Compliance with Iron-Folic 
acid therapy among pregnant women in an urban area of South 
India. Afr Health Sci. 2013; 13(4): 880-885. 
https://doi.org/10.4314/ahs.v13i4.3 PMid:24940307 
PMCid:PMC4056486 
 
10. Iheodorou M. Tsiantou V. Pavalkos A, Maniadakis N, 
Fragoulakis V, Pari E & Kyriopoulos J. Factors influencing 
prescribing behaviour of physician in Greece and Cyprus: Results 
from a questionnaire based survey. BMC Health Services 
Research 2009; 9:150. https://doi.org/10.1186/1472-6963-9-150 
PMid:19695079 PMCid:PMC2737540 
 
11. Agan T, Ekabua J, Udoh A, Ekanem E, Efiok E, Mgbekem M. 
Prevalence of anaemia in women with asymptomatic malaria 
parasitemia at first antenatal care visit at the University of Calabar 
Teaching Hospital, Calabar, Nigeria. Int J Women Health. 
2010;9:229-33. https://doi.org/10.2147/IJWH.S11887 
 
12. WHO Guideline: Daily iron and folic acid supplement in 
pregnant women. Geneva. World Health Organization, 2012. 
(http://www.who.int/nutrition/publications/micronutrients/dail-
iron/folate 
 
13. UNICEF, WHO, UNU. Compositing a multi-micronutrient 
supplement to be used in pilot programs among pregnant women 
in developing countries. Report of a United Nation Children 
Universal (UNN) Workshop held at UNICEF Headquarters, New 
York, July 9, 1999, New York, United Nation Children's Fund, 
2000. http://apps.who.int/iris/andle/10665/75358. 
 
14. WHO. Iron and folte supplementation. Integrated Management 
of Pregnancy and Childbirth (IMPAC). In: Standards for maternal 
and neonatal care 1,8. Geneva. World Health Organization, 2006. 
 
15. Gebemedhin S, Samuel A, Mamo G, Moges T. Coverage, 
Compliance and Factors associated with Utilization of iron 
Suppiementation during pregnancy in eight rural districts of 
Ethiopia: a cross – sectional study. BMC Public Health. 
2014;14:607. https://doi.org/10.1186/1471-2458-14-607 
PMid:24930036 PMCid:PMC4073172 
 
16. Lunet N, Rodrigues T Correta S, Henrique B. Adequacy of 
prenatal Care as a major determinant of folic acid, iron and vitamin 
intake during pregnancy. Cad Saude Publica Rio de Janeiro. 2008; 
24 (5) :1151-1157. https://doi.org/10.1590/S0102-
311X2008000500022 
 
17. Buusmn A, Andersen M, Merrild C. Elverdam B. Factors 
influencing GPs choice between drugs in a therapeutic drug group. 
A qualitative study. Scandinavian Journal of primary health care. 
 
Public Health 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
  6                                                                                                                                                                                                                         http://www.mjms.mk/ 
http://www.id-press.eu/mjms/ 
 
2007; 25: 208-213. https://doi.org/10.1080/02813430701652036 
PMid:18041657 PMCid:PMC3379761 
18. Reichert S, Simun T, Halm E. Physical Attitude about 
prescribing and knowledge of the cost of comm. Medication. 
Achieves of internal medicine. 2000; 160: 2799-2803. 
https://doi.org/10.1001/archinte.160.18.2799 
 
19. Arnoll B, Goodyear-Smith F. Patric, D, Kerse N. Harrison. 
Halliwell, et al. Prescribing information resources: Use and 
preference by general practitioners. The overview, 2005, Report of 
Health Wellington. New Zealand, Ministry of Health, 2005. 
 
 
